Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/6/2019
SIETES contiene 92761 citas

 
 
 1 a 20 de 681 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Tetz G, Brown SM, Hao Y, Tetz V. Parkinson’s disease and bacteriophages as its overlooked contributors. Nature Scientific Reports 2018;8:17 de julio. [Ref.ID 102812]
2.Enlace a cita original Cita con resumen
Ovalle F, Grimes T, Xu G, Patel AJ, Grayson TB, Thielen LA, Li P, Shalev A. Verapamil and beta cell function in adults with recent-onset type 1 diabetes. Nat Med 2018:9 de julio. [Ref.ID 102718]
3. Cita con resumen
Liebmann JM, Cioffi GA. Nicking glaucoma with nicotinamide?. N Engl J Med 2017;376:2079-81. [Ref.ID 101597]
4.Tiene citas relacionadas Cita con resumen
Berkovic SF. Cannabinoids for epilepsy — Real data, at last. N Engl J Med 2017;376:2075-6. [Ref.ID 101596]
5. Cita con resumen
Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet 2017;389:736-47. [Ref.ID 101426]
6.
Scheltens P, Blennow K, Breteler MMB, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM. Alzheimer's disease. Lancet 2016;388:505-17. [Ref.ID 100647]
7.Enlace a cita original Cita con resumen
Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ 2016;353:i1585. [Ref.ID 100339]
8.Tiene citas relacionadas Cita con resumen
Thaçi D, Simpson EL, Beck LA, Bieber T, Blauvelt A, Papp K, Soong W, Worm M, Szepietowski JC, Sofen H, Kawashima M, Wu R, Weinstein SP, Graham NMH, Pirozzi G, Teper A, Sutherland ER, Mastey V, Stahl N, Yancopoulos GD, Ardeleanu M. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet 2016;387:40-52. [Ref.ID 99988]
9.Tiene citas relacionadas
Tsianakas A, Ständer S. Dupilumab: a milestone in the treatment of atopic dermatitis. Lancet 2016;387:4-5. [Ref.ID 99987]
10. Cita con resumen
Ballantyne JC, Sullivan MD. Intensity of chronic pain - The wrong metric?. N Engl J Med 2015;373:2098-9. [Ref.ID 99675]
11. Cita con resumen
Glyn-Jones S, Palmer AJR, Agricola R, Price AJ, Vincent TL, Weinans H, Carr AJ. Osteoarthritis. Lancet 2015;386:376-87. [Ref.ID 99368]
12. Cita con resumen
Villegas S. Enfermedad de Alzheimer: nuevas estrategias terapéuticas. Med Clin (Barc) 2015;145:76-83. [Ref.ID 99323]
13. Cita con resumen
Anónimo. Esclerosis múltiple. PAM 2014;39:452-68. [Ref.ID 99248]
14. Cita con resumen
Anónimo. Incontinences urinaires d'origine médicamenteuse. Prescrire 2015;35:271-4. [Ref.ID 99126]
15.
Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, Roden M, Stein E, Tokgözoglu L, Nordestgaard BG, Bruckert E, De Backer G, Krauss RM, Laufs U, Santos RD, Hegele RA, Hovingh GK, Leiter LA, Mach F, März W, Newman CB, Wiklund O, Jacobson TA, Catapano AL, Chapman MJ, Ginsberg HN. Statin-associated muscle symptoms: impact on statin therapy — European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management (CC) . Eur Heart J 2015;36:1012-22. [Ref.ID 98806]
16.
Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet 2014;384:1878-88. [Ref.ID 98363]
17.Tiene citas relacionadas
Karran E, Hardy J. Antiamyloid therapy for Alzheimer's disease - are we on the right road?. N Engl J Med 2014;370:377-8. [Ref.ID 97062]
18.
Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet 2014;383:69-82. [Ref.ID 97052]
19. Cita con resumen
Kozauer N, Katz R. Regulatory innovation and drug development for early-stage Alzheimer's disease. N Engl J Med 2013;368:1169-71. [Ref.ID 95164]
20.
Ford AC, Talley NJ. Irritable bowel syndrome. BMJ 2012;345:37-42. [Ref.ID 93747]
Seleccionar todas
 
 1 a 20 de 681 siguiente >>